Product lifecycle management in pharmaceuticals

Journal of Medical Marketing

Volumn 12, Issue 3, 2012, Pages 150-158

  Prajapati, Vandana ^a   Dureja, Harish ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Pharmaceuticals; product lifecycle; product lifecycle management; return of investment; strategy

Indexed keywords

EID: 84871791740     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1177/1745790412445292     Document Type: Article

References (31)

1. Norris P. PLM: revenue booster, successful product management supplement, http://www.aspentech.com/publication-files/Successful-Product-Mgmt-PLM-article. pdf (2002, accessed 5 July 2011).
2. Hoogkamer H. and Wernli MH. Product lifecycle and portfolio management, World Pharmaceutical Frontiers, http://www.worldpharmaceuticals.net/pdfs/060- WPF010new.pdf (2006, accessed 7 July 2011).
3. McKiernan J. Achieving business integration across the pharmaceutical value chain, http://ftp.software.ibm.com/software/integration/pdf/pharma- valuechain (2003, accessed 15 July 2011).
4. Lindner JR. Product lifecycle management: IBM Product Lifecycle Management Center of Competency: Consumer packaged goods (CPG) & pharmaceuticals/life sciences, http://www.purdue.edu/discoverypark/PLM/pdf/plm- johnlindner.pdf (2004, accessed 5 July 2011).
5. Patent lifecycle management, http://ebookbrowse.com/patent-life-cycle- management-ppt-d16388914 (2010, accessed 25 July 2011).
6. Tuttle E, Parece A and Hector A. Beyond lifecycle management - optimizing performance following patent expiry, www.analysisgroup.com/uploadedFiles/ Publishing/Articles/Patent-Expiry (2004, accessed 2 August 2011).
7. Brian J, Buono D and Kevin WC. Evolving product lifecycle management approaches, http://64.237.99.107/media/pnc/media.1001.pdf (2009, accessed 15 July 2011).
8. King J. Can a drug live forever? http://65.17.196.124/pdf/live.pdf (2003, accessed 5 July 2011).
9. Adair D. Blockbuster protection. Intellectual Property Right Magazine, 35-37 January 2011, http://www.bristows.co.uk/assets/documents/IPM.pdf (accessed 23 August 2011).
10. Addressing the challenges of product lifecycle management, http://www.hr.capgemini.com/m/hr/tl/Addressing-the-Challenges-of-Product- Lifecycle-Management.pdf (2007, accessed 23 August 2011).
11. Stark J Product lifecycle management: 21st century paradigm for product realisation. London: Springer-Verlag ; 2011: 2, 6, 375-2, 6, 375.
12. New-product development and product life-cycle strategies, http://people.arcada.fi/~eldons/Marketing%202011]/Marketing%202011]/ Life%20cycle%20strategies%2014.ppt (2008, accessed 6 August 2011).
13. Komninos I. Product life cycle management, http://urenio.org/tools/en/ Product-Life-Cycle-Management.pdf (2002, accessed 1 July 2011).
14. Itkar S Pharmaceutical management. Pune: Nirali Prakashan ; 2007: 3, 12-17.
15. Unlocking the value of pharmaceutical products: a new perspective for product lifecycle management, http://www.ru.capgemini.com/m/ru/tl/Vision-amp- Reality-Research-2004.pdf (2004, accessed 2 July 2011).
16. NMEs approved by CDER, http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ DrugandBiologicApprovalReports/UCM242695 (2011, accessed 2 October 2011).
17. Dennis ZK. Product lifecycle management: marketing strategies for the pharmaceutical industry. J Med Market: Device Diagn Pharmaceutical Market. 2008 ; 8: 293-293
18. Adams CP, Brantner VV. Estimating the cost of new drug development: is it really $802 million?. Health Aff. 2006 ; 25 (2). 420-428
19. PhRMA profile: pharmaceutical industry 2011, http://www,phrma.org/sites/ default/files/159/phrma-profile-2011-final.pdf (2011, accessed 18 December 2011).
20. Kaitin KI. Deconstructing the drug development process: the new face of innovation. Clin Pharmacol Ther. 2010 ; 87 (3). 356-361
21. Cha M. Pharma-biotech alliances: a case study, http://leda.law.harvard. edu/leda/data/625/Cha-redacted.html (2004, accessed 23 August 2011).
22. Rebecca SY and Ellen SC. Pharmaceutical reformulation: the growth of life cycle management. J Health Law Policy 2007; 1: 379-410. http://www.law.uh.edu/ hjhlp/issues/vol-72/yoshitani-cooper.pdf (accessed 1 August 2011).
23. Product enhancement and product life cycle management through strategic pharmaceutical journey using science, technology, and innovation, http://riconpharma.com/html/docs/ProductEnhancement-and-LifeCyclePlanning.pdf (2009, accessed 7 July 2011).
24. Mitchell R and Bingham D. Rules to live or die by for life cycle management, http://www.pharmaquality.com/ME2/Audiences/dirmod.asp?sid= 325598564E8C4B3EB736C7159241312D+nm=Browse+Articles+type=Publishing+mod= Publications%3A%3AArticle+mid=D3E3C719D8D44216836DCA4F4144BEC4+tier=4+id= 2482698BE7B7474F8A875B62C100DD58+AudID=5648A5C28C97462DBBDB309539B820EF (2009, accessed 29 July 2011).
25. Silverman E. What managed care thinks of Pfizer and its Lipitor strategy, http://news.yahoo.com/managed-care-thinks-pfizer-lipitor-strategy-172445712. html (2011, accessed 2 December 2011).
26. Bowe C. Lessons in lifecycle management: case studies, http://www.scripintelligence.com/multimedia/archive/00142/056-Life-Cycle-Mana- 142495a.pdf (2011, accessed 8 August 2011).
27. Sanburn J. Lipitor already cheaper after patent expiration, http://moneyland.time.com/2011/12/01/lipitor-patent-expiration-wont-meancheaper- generic-yet/ (2011, accessed 4 December 2011).
28. Mathew JC. Chemical ministry may ask industry to start process of bi-lingual labelling by April 18, http://www.cipi.in/news110406pb.htm (2006, accessed 18 December 2011).
29. Mathew JC. IPA to submit sample bilingual packs by September 20, http://www.cipi.in/news310806pb.htm (2006, accessed 18 December 2011).
30. Jayakumar PB. Centre now says bi-lingual labelling only a voluntary provision, http://www.cipi.in/news2612062pb.htm (2006, accessed 18 December 2011).
31. Sharma A. Wait is on: pharma cos yet to go bilingual, http://www.tribune.com/2007/20070321/himplus1.htm (2007, accessed 18 December 2011).